Compare companies
Arcus Biosciences, Inc. | Humana | Johnson & Johnson | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 8.4 | 273.77 | 161.02 | |||
Price priv. | ||||||
Number of shares, million | 74 | 124.44 | 2560.4 | |||
Capitalization, billion | 1.42 | 60.76 | 448.3 | |||
EBITDA, billion | -0.291 | 4.73 | 29.34 | |||
EV, billion | 1.23 | 63.97 | 405.51 | |||
Profit and loss report | ||||||
Net profit, billion | -0.307 | 2.49 | 35.15 | |||
Revenue, billion | 0.117 | 106.37 | 85.15 | |||
EPS | -4.15 | 20 | 13.73 | |||
Balance | ||||||
Assets, billion | 1.1 | 47.07 | 167.56 | |||
Debt, billion | 0.011 | 11.83 | 29.33 | |||
Balance cost, billion | 0.462 | 16.26 | 68.77 | |||
Cash, billion | 0.127 | 4.69 | 21.86 | |||
Coefficients | ||||||
Dividend yield, % | 0 | 1.17 | 3.1 | |||
Dividend | 0 | 3.54 | 4.96 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 0 | 17.32 | 33.48 | |||
P/S | 11.48 | 0.5302 | 4.67 | |||
P/BV | 2.91 | 1.53 | 5.79 | |||
P/E | 15.42 | 22.66 | 11.32 | |||
Ev/Ebitda | -4.22 | 13.52 | 13.82 | |||
Debt/Ebitda | -0.0378 | 2.5 | 0.9998 | |||
Efficiency | ||||||
ROE | -66.45 | 15.31 | 51.11 | |||
ROA | -28.04 | 5.29 | 20.98 | |||
ROIC | 7.17 | -3.8 | 19.19 | |||
Ebitda margin | -248.72 | 4.45 | 34.45 | |||
Net margin | -262.39 | 2.34 | 41.28 | |||
Momentum | ||||||
1 week, price changes | -7.59 % | +2.41 % | -1.21 % | |||
1 month, price changes | -17.32 % | +7.36 % | -1.66 % | |||
3 months, price changes | -47.2 % | +7.14 % | +10.4 % | |||
6 months, price changes | -45.42 % | -12.54 % | -0.2293 % | |||
1 year, price changes | -49.55 % | -21.42 % | +3.37 % | |||
3 years, price changes | -77.74 % | -36.98 % | -11.32 % | |||
5 years, price changes | -39.87 % | -32 % | +3.65 % | |||
10 years, price changes | +46.86 % | +31.07 % |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription